Boehringer Ingelheim — Drug Prices & Medicare Spending

Boehringer Ingelheim manufactures 15 drugs tracked by Medicare Part D with total spending of $8.5B.

Drugs Tracked

$8.5B

Medicare Spending

$99.77

Avg Cost/Claim

100%

Have Generics

Boehringer Ingelheim Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Jardiance	Empagliflozin	$210.00	$3.9B	+22.7%	Yes
2	Spiriva	Tiotropium	$146.00	$912.0M	-8.9%	Yes
3	Pradaxa	Dabigatran	$180.00	$876.0M	-9.8%	Yes
4	Synjardy	Empagliflozin/Metformin	$175.00	$567.0M	+14.2%	Yes
5	Tradjenta	Linagliptin	$134.00	$567.0M	-4.2%	Yes
6	Stiolto Respimat	Tiotropium/Olodaterol	$189.00	$234.0M	-6.8%	Yes
7	Empagliflozin	Empagliflozin	$48.00	$234.0M	+14.6%	Yes
8	Glyxambi	Empagliflozin/Linagliptin	$189.00	$234.0M	+4.6%	Yes
9	Aggrenox	Aspirin/Dipyridamole	$72.00	$178.0M	-22.4%	Yes
10	Jentadueto	Linagliptin/Metformin	$144.00	$178.0M	-4.8%	Yes
11	Tamsulosin	Tamsulosin Hydrochloride	$8.00	$123.0M	-24.6%	Yes
12	Pramipexole	Pramipexole Dihydrochloride	$50.00	$123.0M	-18.4%	Yes
13	Gilotrif	Afatinib	$8,786.00	$123.0M	-18.6%	Yes
14	Meloxicam	Meloxicam	$6.00	$89.0M	-22.4%	Yes
15	Telmisartan	Telmisartan	$18.00	$89.0M	-14.2%	Yes

Frequently Asked Questions

Boehringer Ingelheim manufactures 15 drugs tracked by Medicare Part D, with total annual spending of $8.5B.

Gilotrif (Afatinib) is the most expensive at $8,786.00 per claim.

15 of 15 Boehringer Ingelheim drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.